Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple hormone pill help prevent early delivery?

NCT ID NCT07523295

Disease control Sponsor: Medicare Hospital (Pvt) Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving vaginal progesterone to women who have had preterm labor can help them stay pregnant longer and improve their baby's health. Sixty pregnant women between 24 and 34 weeks will first receive standard care to stop labor, then half will get daily progesterone while the other half gets routine advice. Researchers will track how long until delivery, rates of preterm birth, and birth weight.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Progesterone vaginal capsules (400 mg daily)
What this could lead to
If it works, this could provide a simple way to reduce preterm births and improve newborn health in women who have had preterm labor.
What could go wrong
This is a small, single-center trial with only 60 participants, so results may not apply widely. Progesterone may not significantly extend pregnancy or prevent complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

60 people

The number who actually took part.

Started

May 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women with singleton pregnancies (on antenatal scan) * Presenting with pr-term labor * Between 24 - 34 weeks of gestation * Treated successfully with acute tocolysis for 48 hours and received steroids Exclusion Criteria: * Women with multiple pregnancy * Preterm premature rupture of membranes * Cervical dilatation \>3 cm (clinical examination) * Congenital fetal anomalies * Refuse to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Preterm birth are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Preterm birth Preterm labor with intact membranes

Contacts and locations

Locations

  • Medicare Hospital (Pvt) Limited

    Multan, Punjab Province, 60000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.